Cargando…

Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2

CYP2B proteins in rat hepatocytes undergo NO-dependent proteolytic degradation, but the mechanisms and the reasons for the specificity towards only certain P450 (cytochrome P450) enzymes are yet unknown. In the present study we found that down-regulation of CYP2B proteins by the NO donor NOC-18 is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Haiyan, Lee, Choon-myung, Tripathi, Shweta, Kim, Kyung-Bo, Morgan, Edward T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557507/ https://www.ncbi.nlm.nih.gov/pubmed/22612225 http://dx.doi.org/10.1042/BJ20120820

Ejemplares similares

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
por: Rutkowska, Justyna, et al.
Publicado: (2023)

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
por: French, Timothy, et al.
Publicado: (2021)

Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders
por: Kimura, Hiroaki, et al.
Publicado: (2015)

Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis
por: Hewing, Bernd, et al.
Publicado: (2017)

The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice
por: Wang, Shuai, et al.
Publicado: (2018)

Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7
por: Vachharajani, Niyati, et al.
Publicado: (2017)

Airway epithelial immunoproteasome subunit LMP7 protects against rhinovirus infection
por: Dimasuay, Kris Genelyn, et al.
Publicado: (2022)

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders
por: Ugras, Scott, et al.
Publicado: (2018)

Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers
por: Lee, Miseon, et al.
Publicado: (2019)

Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice
por: Koerner, Julia, et al.
Publicado: (2017)

Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus Myocarditis
por: Opitz, Elisa, et al.
Publicado: (2011)

A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
por: Wehenkel, M, et al.
Publicado: (2012)

The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021)

Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R
por: Yan, Wen, et al.
Publicado: (2020)

Inhibition of the Immunoproteasome Subunit LMP7 Ameliorates Cerebral White Matter Demyelination Possibly via TGFβ/Smad Signaling
por: Chen, Xingyong, et al.
Publicado: (2021)

Ageing-related changes in the levels of β-catenin, CacyBP/SIP, galectin-3 and immunoproteasome subunit LMP7 in the heart of men
por: Kasacka, Irena, et al.
Publicado: (2020)

M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
por: Sanderson, Michael P., et al.
Publicado: (2021)

Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma
por: Piotrowska, Żaneta, et al.
Publicado: (2020)

Expression Pattern of Immunoproteasome Subunits in Human Thymus
por: Oh, Kwon Ik, et al.
Publicado: (2009)

Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population
por: Mishto, Michele, et al.
Publicado: (2010)

Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
por: Chen, Xing-Yong, et al.
Publicado: (2021)

HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation
por: Yang, Yang, et al.
Publicado: (2020)

Immunoproteasome impairment via β5i/LMP7‐deletion leads to sustained pancreatic injury from experimental pancreatitis
por: de Freitas Chama, Laura L., et al.
Publicado: (2021)

The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
por: Xie, Xin, et al.
Publicado: (2019)

The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation
por: Shah, Khilan M., et al.
Publicado: (2009)

Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
por: Hayashi, Takuma, et al.
Publicado: (2011)

Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits
por: Griffin, Thomas A., et al.
Publicado: (1998)

A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential
por: Huber, Eva M., et al.
Publicado: (2021)

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
por: Maia Falcão, Raul, et al.
Publicado: (2022)

A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease
por: Yeo, In Jun, et al.
Publicado: (2019)

β5i Subunit Deficiency of the Immunoproteasome Leads to Reduced Th2 Response in OVA Induced Acute Asthma
por: Volkov, Anton, et al.
Publicado: (2013)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)

Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
por: Zhou, Hefeng, et al.
Publicado: (2019)

SAT652 The Expression Of The Immunoproteasome Subunit Psmb9 Is Related To Obesity And The Differentiation Of Human Preadipocytes
por: Cui, Yan, et al.
Publicado: (2023)

Regulation of Immunoproteasome Function in the Lung
por: Keller, Ilona E., et al.
Publicado: (2015)

Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016)

On the Role of the Immunoproteasome in Protein Homeostasis
por: Basler, Michael, et al.
Publicado: (2021)

The Function of Immunoproteasomes—An Immunologists’ Perspective
por: van den Eshof, Bart L., et al.
Publicado: (2021)

Induction and Regulation of the Immunoproteasome Subunit β5i (PSMB8) in Laryngeal and Hypopharyngeal Carcinoma Cells
por: Chen, Nan-Xiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_00tdm22regvj9ppjbvhujn1pbl